Catalyst Biosciences financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

크레센트 바이오파머NASDAQ:CBIO · Nasdaq

$13.49-0.59%

2026-10-07 close

Catalyst Biosciences's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$40M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy